SR9011 1 mg | 99.60%
TargetMol
SR9011 is a REV-ERB agonist (IC50: 790 nM, REV-ERBα; IC50: 560 nM, REV-ERBβ).
More Information Supplier PageSR9011
Search Results
1-Deoxynojirimycin 100 mg | 99.82%
TargetMol
1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
More Information Supplier Page1-Deoxynojirimycin
1-Deoxynojirimycin 2 mg | 99.82%
TargetMol
1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
More Information Supplier Page1-Deoxynojirimycin
Eliglustat 100 mg | 99.71%
TargetMol
Eliglustat is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease.
More Information Supplier PageEliglustat
Paritaprevir 100 mg | 99.57%
TargetMol
Paritaprevir is an orally bioavailable, synthetic acylsulfonamide inhibitor of the hepatitis C virus (HCV) protease complex comprised of non-structural protein 3 and 4A (NS3/NS4A), with potential activity against HCV genotype 1. Upon administration, paritaprevir reversibly binds to the active center and binding site of the HCV NS3/NS4A protease and prevents NS3/NS4A protease-mediated polyprotein maturation. This […]
More Information Supplier PageParitaprevir
Paritaprevir 200 mg | 99.57%
TargetMol
Paritaprevir is an orally bioavailable, synthetic acylsulfonamide inhibitor of the hepatitis C virus (HCV) protease complex comprised of non-structural protein 3 and 4A (NS3/NS4A), with potential activity against HCV genotype 1. Upon administration, paritaprevir reversibly binds to the active center and binding site of the HCV NS3/NS4A protease and prevents NS3/NS4A protease-mediated polyprotein maturation. This […]
More Information Supplier PageParitaprevir
PF3274167 25 mg | Purity Not Available
TargetMol
PF-3274167 is a potent and selective, high-affinity nonpeptide oxytocin receptor antagonist.
More Information Supplier PagePF3274167
Calycosin-7-O-β-D-glucoside 5 mg | 99.71%
TargetMol
Calycosin-7-O-β-D-glucoside (calycosin-7-O-beta-D-glucopyranoside) possesses a protective effect on rat hepatocytes, an inhibitory effect on COX-2 activity. Calycosin 7-O-β-D-glucoside has antimicrobial activity. Calycosin 7-O-β-D-glucoside is a promising anti-HIV agent. It shows scavenging activity to DPPH radicals and superoxide anion. Calycosin 7-O-β-D-glucopyranoside possesses an alleviating effect on osteoarthritis and can increase the fluidity of brain cell membrane in […]
More Information Supplier PageCalycosin-7-O-β-D-glucoside
Calycosin-7-O-β-D-glucoside 25 mg | 99.71%
TargetMol
Calycosin-7-O-β-D-glucoside (calycosin-7-O-beta-D-glucopyranoside) possesses a protective effect on rat hepatocytes, an inhibitory effect on COX-2 activity. Calycosin 7-O-β-D-glucoside has antimicrobial activity. Calycosin 7-O-β-D-glucoside is a promising anti-HIV agent. It shows scavenging activity to DPPH radicals and superoxide anion. Calycosin 7-O-β-D-glucopyranoside possesses an alleviating effect on osteoarthritis and can increase the fluidity of brain cell membrane in […]
More Information Supplier PageCalycosin-7-O-β-D-glucoside
Calycosin-7-O-β-D-glucoside 100 mg | 99.71%
TargetMol
Calycosin-7-O-β-D-glucoside (calycosin-7-O-beta-D-glucopyranoside) possesses a protective effect on rat hepatocytes, an inhibitory effect on COX-2 activity. Calycosin 7-O-β-D-glucoside has antimicrobial activity. Calycosin 7-O-β-D-glucoside is a promising anti-HIV agent. It shows scavenging activity to DPPH radicals and superoxide anion. Calycosin 7-O-β-D-glucopyranoside possesses an alleviating effect on osteoarthritis and can increase the fluidity of brain cell membrane in […]
More Information Supplier PageCalycosin-7-O-β-D-glucoside